{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-24-090366","form_type":"8-K","ticker":"INMB","cik":"0001711754","company_name":"Inmune Bio, Inc.","filed_at":"2024-10-24T23:59:59+00:00","discovered_at":"2026-05-14T18:03:09.309405+00:00","generated_at":"2026-05-30T10:33:39.922060+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"confidence":"high","headline":"INmune Bio schedules Q3 2024 earnings call for Oct 31 at 4:30pm EDT","bullets":["Press release issued Oct 24, 2024 announcing conference call date.","Call on Thursday, October 31, 2024 at 4:30pm ET to discuss Q3 results and corporate update.","Dial-in: 1-800-343-4136 (US), 1-203-518-9843 (intl); Conference ID: INMUNE.","Webcast and replay available; transcript expected within 24 hours of call."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-24-090366","json":"https://secwatch.observer/filing/0001213900-24-090366.json","markdown":"https://secwatch.observer/filing/0001213900-24-090366.md","text":"https://secwatch.observer/filing/0001213900-24-090366.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1711754/000121390024090366/0001213900-24-090366-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1711754/000121390024090366/ea0218524-8k_inmune.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T10:33:39.922060+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}